PL2012764T3 - Kombinacja farmaceutyczna zawierająca 3-(3-dimetyloamino-1-etylo-2-metylopropylo)fenol i Paracetamol - Google Patents

Kombinacja farmaceutyczna zawierająca 3-(3-dimetyloamino-1-etylo-2-metylopropylo)fenol i Paracetamol

Info

Publication number: PL2012764T3
Authority: PL; Poland
Prior art keywords: paracetamol; dimethylamino; phenol; propyl; ethyl
Prior art date: 2006-04-28

Application number

PL07724562T

Other languages

English (en)

Inventor

Petra Bloms-Funke

Klaus Schiene

Original Assignee

Gruenenthal Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-04-28

Filing date

2007-04-25

Publication date

2011-04-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37025148&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2012764(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2007-04-25 Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh

2011-04-29 Publication of PL2012764T3 publication Critical patent/PL2012764T3/pl

Links

KWTWDQCKEHXFFR-UHFFFAOYSA-N 3-[1-(dimethylamino)-2-methylpentan-3-yl]phenol Chemical compound CN(C)CC(C)C(CC)C1=CC=CC(O)=C1 KWTWDQCKEHXFFR-UHFFFAOYSA-N 0.000 title abstract 2
RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 title abstract 2
229960005489 paracetamol Drugs 0.000 title abstract 2
208000002193 Pain Diseases 0.000 abstract 3
241000124008 Mammalia Species 0.000 abstract 2
208000000094 Chronic Pain Diseases 0.000 abstract 1
208000005298 acute pain Diseases 0.000 abstract 1
230000001684 chronic effect Effects 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
239000002552 dosage form Substances 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
230000037361 pathway Effects 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Pain & Pain Management (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Emergency Medicine (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Rheumatology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PL07724562T 2006-04-28 2007-04-25 Kombinacja farmaceutyczna zawierająca 3-(3-dimetyloamino-1-etylo-2-metylopropylo)fenol i Paracetamol PL2012764T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP06008851		2006-04-28
EP07724562A EP2012764B1 (en)	2006-04-28	2007-04-25	Pharmaceutical combination comprising 3-(3-dimethylamino-1-ethyl-2-methyl-propyl) -phenol and paracetamol
PCT/EP2007/003632 WO2007128413A1 (en)	2006-04-28	2007-04-25	Pharmaceutical combination comprising 3- ( 3-dimethylamino-1-ethyl-2-methyl-propyl) -phenol and paracetamol

Publications (1)

Publication Number	Publication Date
PL2012764T3 true PL2012764T3 (pl)	2011-04-29

Family

ID=37025148

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL07724562T PL2012764T3 (pl)	2006-04-28	2007-04-25	Kombinacja farmaceutyczna zawierająca 3-(3-dimetyloamino-1-etylo-2-metylopropylo)fenol i Paracetamol

Country Status (24)

Country	Link
EP (1)	EP2012764B1 (pl)
JP (2)	JP5496653B2 (pl)
KR (1)	KR101396166B1 (pl)
CN (1)	CN101431990B (pl)
AT (1)	ATE494889T1 (pl)
AU (1)	AU2007247481B2 (pl)
BR (1)	BRPI0710682B8 (pl)
CA (1)	CA2650423C (pl)
CY (1)	CY1111369T1 (pl)
DE (1)	DE602007011913D1 (pl)
DK (1)	DK2012764T3 (pl)
EC (2)	ECSP088793A (pl)
ES (1)	ES2356093T3 (pl)
HR (1)	HRP20110076T1 (pl)
IL (1)	IL194883A (pl)
MX (1)	MX2008013779A (pl)
NO (2)	NO341602B1 (pl)
NZ (1)	NZ571442A (pl)
PL (1)	PL2012764T3 (pl)
PT (1)	PT2012764E (pl)
RU (1)	RU2442576C2 (pl)
SI (1)	SI2012764T1 (pl)
WO (1)	WO2007128413A1 (pl)
ZA (1)	ZA200810124B (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102007012165A1 (de) *	2007-03-12	2008-09-18	Grünenthal GmbH	Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie des Neuropathieschmerzes
CN102065852B (zh) *	2007-11-23	2015-06-17	格吕伦塔尔有限公司	他喷他多组合物
JP6133772B2 (ja)	2010-06-15	2017-05-24	グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング	痛み治療用の医薬配合物
MX374468B (es)	2011-03-04	2025-03-06	Gruenenthal Gmbh	Composicion farmaceutica acuosa semisolida que contiene tapentadol.
MX369121B (es)	2011-03-04	2019-10-30	Gruenenthal Gmbh	Formulacion farmaceutica acuosa de tapentadol para administracion oral.
EA024193B1 (ru)	2011-03-04	2016-08-31	Грюненталь Гмбх	Фармацевтическая композиция на водной основе, предназначенная для парентерального введения тапентадола
US9855286B2 (en)	2012-05-18	2018-01-02	Gruenenthal Gmbh	Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-di methyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a salicylic acid component
US20130310385A1 (en)	2012-05-18	2013-11-21	Gruenenthal Gmbh	Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine and Antidepressants
US20130310435A1 (en) *	2012-05-18	2013-11-21	Gruenenthal Gmbh	Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N, N-dimethyl-4-phenyl-4,9' -dihydro-3'H-spiro[cyclohexane-1,1' -pyrano[3,4,b]indol]-4-amine and Paracetamol or Propacetamol
US9320729B2 (en)	2012-05-18	2016-04-26	Gruenenthal Gmbh	Pharmaceutical composition comprising (1r,4r)-6′-flouro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative
EP2808319A1 (en)	2013-05-31	2014-12-03	Arevipharma GmbH	3-[3-(Dimethylamino)-1-ethyl-2-methylpropyl]phenol resin complex
EA036258B1 (ru)	2015-03-27	2020-10-20	Грюненталь Гмбх	Стабильный препарат для парентерального введения тапентадола
CN109996533A (zh)	2016-09-23	2019-07-09	格吕伦塔尔有限公司	用于肠胃外施用他喷他多的稳定制剂
EP3585370A1 (en)	2017-02-23	2020-01-01	Grünenthal GmbH	Tapentadol as local anesthetic

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4426245A1 (de) *	1994-07-23	1996-02-22	Gruenenthal Gmbh	1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
PE20030527A1 (es) *	2001-10-24	2003-07-26	Gruenenthal Chemie	Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen
ATE391498T1 (de)	2002-11-22	2008-04-15	Gruenenthal Gmbh	Verwendung von (1rs,3rs,6rs)-6- dimethylaminomethyl-1-(3-methoxy-phenyl)- cyclohexan-1,3-diol zur behandlung von entzündungsschmerz

2007
- 2007-04-25 WO PCT/EP2007/003632 patent/WO2007128413A1/en not_active Ceased
- 2007-04-25 SI SI200730498T patent/SI2012764T1/sl unknown
- 2007-04-25 EP EP07724562A patent/EP2012764B1/en active Active
- 2007-04-25 ES ES07724562T patent/ES2356093T3/es active Active
- 2007-04-25 MX MX2008013779A patent/MX2008013779A/es active IP Right Grant
- 2007-04-25 JP JP2009506978A patent/JP5496653B2/ja not_active Expired - Fee Related
- 2007-04-25 DE DE602007011913T patent/DE602007011913D1/de active Active
- 2007-04-25 CN CN2007800148115A patent/CN101431990B/zh not_active Expired - Fee Related
- 2007-04-25 RU RU2008146816/15A patent/RU2442576C2/ru active
- 2007-04-25 BR BRPI0710682A patent/BRPI0710682B8/pt active IP Right Grant
- 2007-04-25 PL PL07724562T patent/PL2012764T3/pl unknown
- 2007-04-25 AT AT07724562T patent/ATE494889T1/de active
- 2007-04-25 CA CA2650423A patent/CA2650423C/en active Active
- 2007-04-25 HR HR20110076T patent/HRP20110076T1/hr unknown
- 2007-04-25 NZ NZ571442A patent/NZ571442A/en not_active IP Right Cessation
- 2007-04-25 KR KR1020087028929A patent/KR101396166B1/ko not_active Expired - Fee Related
- 2007-04-25 DK DK07724562.9T patent/DK2012764T3/da active
- 2007-04-25 PT PT07724562T patent/PT2012764E/pt unknown
- 2007-04-25 AU AU2007247481A patent/AU2007247481B2/en not_active Ceased
2008
- 2008-10-06 EC EC2008008793A patent/ECSP088793A/es unknown
- 2008-10-23 IL IL194883A patent/IL194883A/en active IP Right Grant
- 2008-10-28 NO NO20084542A patent/NO341602B1/no unknown
- 2008-11-27 ZA ZA200810124A patent/ZA200810124B/xx unknown
2011
- 2011-04-05 CY CY20111100353T patent/CY1111369T1/el unknown
2013
- 2013-07-11 JP JP2013145481A patent/JP2013213045A/ja not_active Withdrawn
2017
- 2017-01-05 EC ECIEPI2017643A patent/ECSP17000643A/es unknown
- 2017-11-17 NO NO20171831A patent/NO343505B1/no unknown

Also Published As

Publication number	Publication date
NO20084542L (no)	2008-10-28
JP2013213045A (ja)	2013-10-17
ZA200810124B (en)	2009-08-26
HRP20110076T1 (hr)	2011-02-28
EP2012764A1 (en)	2009-01-14
AU2007247481A1 (en)	2007-11-15
MX2008013779A (es)	2008-11-14
IL194883A0 (en)	2009-08-03
CY1111369T1 (el)	2015-08-05
BRPI0710682B1 (pt)	2020-09-24
BRPI0710682B8 (pt)	2021-05-25
KR101396166B1 (ko)	2014-05-27
CN101431990A (zh)	2009-05-13
AU2007247481B2 (en)	2013-02-14
NO341602B1 (no)	2017-12-11
ATE494889T1 (de)	2011-01-15
RU2442576C2 (ru)	2012-02-20
BRPI0710682A2 (pt)	2011-08-23
NO343505B1 (no)	2019-03-25
IL194883A (en)	2012-10-31
PT2012764E (pt)	2011-02-02
DE602007011913D1 (de)	2011-02-24
WO2007128413A1 (en)	2007-11-15
CA2650423C (en)	2014-08-12
NO20171831A1 (no)	2008-10-28
NZ571442A (en)	2011-09-30
ECSP17000643A (es)	2018-06-30
JP5496653B2 (ja)	2014-05-21
DK2012764T3 (da)	2011-02-28
JP2009535313A (ja)	2009-10-01
ES2356093T3 (es)	2011-04-04
ECSP088793A (es)	2008-11-27
HK1127289A1 (en)	2009-09-25
CN101431990B (zh)	2011-08-03
SI2012764T1 (sl)	2011-03-31
EP2012764B1 (en)	2011-01-12
KR20090006219A (ko)	2009-01-14
CA2650423A1 (en)	2007-11-15
RU2008146816A (ru)	2010-06-10

Publication	Publication Date	Title
IL194883A0 (en)	2009-08-03	Pharmaceutical combination comprising 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol and paracetamol
IL194885A0 (en)	2009-08-03	Pharmaceutical combination comprising 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol and an nsaid
AU2016219643A1 (en)	2016-09-15	Pharmaceutical combination for the treatment of pain
WO2007143607A3 (en)	2008-02-21	Method of treating atrophic vaginitis
WO2008148074A3 (en)	2009-03-19	Inhibitors of mtor and methods of treatment using same
EA200900264A1 (ru)	2009-08-28	Композиции флибансерина и способ их приготовления
WO2007070052A3 (en)	2009-04-16	Pharmaceutical compositions and methods for treating or preventing oxalate-related disease
WO2011099832A3 (en)	2012-01-12	Novel benzimidazole compound, preparation method thereof and pharmaceutical composition comprising the same
BRPI0922789A2 (pt)	2019-10-15	peptídeo de ligação de albumina intermediador para reconhecimento de doença
WO2009021058A3 (en)	2010-01-14	Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy
WO2008131056A3 (en)	2009-12-03	Sustained release monoeximic formulations of opioid and nonopioid analgesics
WO2007138466A3 (en)	2009-04-23	Pharmaceutical compositions comprising meloxicam and tramadol combination
WO2008124505A3 (en)	2009-08-20	Soluble guanylate cyclase (sgc) modulators for treatment of lipid related disorders
UA103614C2 (uk)	2013-11-11	Лікарський засіб, що містить комбінацію інгібітора кінази та анти-гліпікан 3-антитіла, для лікування раку печінки
WO2006138608A3 (en)	2007-04-26	Pharmaceutical compositions and use thereof
MX2009011900A (es)	2010-01-20	Curacion de herida diabetica.
WO2008070010A3 (en)	2008-07-24	Hydroxylamine derivatives for the treatment of stroke
WO2008012796A3 (en)	2009-04-09	Pharmaceutical compositions comprising ccl2 and use of same for the treatment of inflammation
WO2008075320A3 (en)	2008-08-14	Antilipidemic pharmaceutical compositions and process for preparation thereof
WO2008008882A3 (en)	2008-05-02	Glucocorticoid receptor modulator and methods of use
WO2006055352A3 (en)	2006-07-27	Methods of treating cancer with lipid-based platinum compound formulations administered intraperitoneally
WO2007056236A3 (en)	2007-09-20	Methods of treating cancer with lipid-based platinum compound formulations administered intravenously
TW200744676A (en)	2007-12-16	Pharmaceutical compositions for the eradication of helicobacter pylori
WO2007084383A3 (en)	2008-07-24	Method and composition for the treatment of parkinson's disease
WO2014170820A3 (en)	2015-02-19	A pharmaceutical combination for treating tuberculosis